Prognosis Value of Non-invasive Methods for the Diagnosis of Chronic Liver Disease — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Prognosis Value of Non-invasive Methods for the Diagnosis of Chronic Liver Disease — Stella

Home/Chronic Liver Disease/

View on ClinicalTrials.gov

Recruiting

Back to Chronic Liver Disease trials

Trial locations(1 site)

France

Centre d'Investigation de la Fibrose hépatique Service Hépato-Gastroentérologie Hopital Haut-Lévèque, Pessac

Key details

Sponsor

Association HGE CHU Bordeaux Sud

Enrollment target

~10,000 participants

Started

February 2014

Primary completion

January 2030

Age range

18 Years and older

Last updated July 2023

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.